Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 118,208 | 100,332 | -17,876 | $37.7K | $36.0K | 20.15% | -$1.7K |
| Exelixis, Inc.(EXEL) | 1,677,393 | 1,281,612 | -395,781 | $37.7K | $33.3K | 18.64% | -$4.4K |
| Cardinal Health, Inc.(CAH) | 217,656 | 210,263 | -7,393 | $21.4K | $23.2K | 13.02% | +$1.8K |
| Biogen Inc.(BIIB) | 123,785 | 113,502 | -10,283 | $28.7K | $22.0K | 12.33% | -$6.7K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 1,251,338 | 1,498,074 | +246,736 | $16.2K | $15.5K | 8.70% | -$710 |
| Jazz Pharmaceuticals plc(JAZZ) | 109,076 | 110,257 | +1,181 | $11.6K | $12.3K | 6.88% | +$642 |
| BioNTech SE(BNTX) | 132,293 | 93,583 | -38,710 | $10.6K | $11.1K | 6.23% | +$484 |
| Sanofi(SNY) | 153,832 | 150,205 | -3,627 | $7.5K | $8.7K | 4.85% | +$1.2K |
| Alkermes plc(ALKS) | 257,554 | 251,495 | -6,059 | $6.2K | $7.0K | 3.94% | +$832 |
| Indivior Plc | 0 | 701,873 | +701,873 | $0 | $6.8K | 3.83% | +$6.8K |
| Vanda Pharmaceuticals Inc.(VNDA) | 662,166 | 414,684 | -247,482 | $3.7K | $1.9K | 1.09% | -$1.8K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 7,853 | 353 | -7,500 | $8.3K | $371 | 0.21% | -$7.9K |
| Mural Oncology Plc | 75,057 | 75,868 | +811 | $236 | $237 | 0.13% | +$1 |
| Taro Pharmaceutical Indus | 650,089 | 0 | -650,089 | $28.0K | $0 | — | -$28.0K |